Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support (a) research and (b) development into medical treatments for people affected by COVID-19 vaccine injury.

The Department commissions research through the National Institute for Health and Care Research (NIHR), and continues to welcome funding applications for research into any aspect of human health, including treatments for vaccine side effects. Since the start of the pandemic, the NIHR has allocated more than £110 million of funding for COVID-19 vaccine research, including consideration of issues around vaccine safety. As part of this, the Department commissioned a £1.6 million programme of work through the NIHR, to understand the mechanisms underlying the occurrence of COVID-19 vaccine-induced thrombotic thrombocytopenia syndrome, a rare condition of blood clotting with low platelets following vaccination for COVID-19. This research was published in July 2025.

In the very rare event where an individual may have suffered a severe adverse reaction to a COVID-19 vaccine, care and treatment will be best met and managed by National Health Service local specialist services, augmented as appropriate by national specialist advice.